Announcements Trials
Browse Landscape

Status

Completed 5Withdrawn 1

Sponsor Class

INDUSTRY 5

Study Type

Observational 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 30Prostatic Neoplasms, Castration-Resistant 5Neoplasm Metastasis 5Breast Neoplasms 3Prostate Carcinoma Metastatic to the Bone 2Neoplasms 2Hormone Refractory Prostate Cancer 2Bone Metastatic Castration-resistant Prostate Cancer 2Thyroid Neoplasms 1Prostate Cancer Metastatic to Bone 1Pain 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer (mCRPC) 1Lung Neoplasms 1Fractures, Bone 1Fatigue 1Castration-resistant Prostate Cancer 1Castrate-Resistant Prostate Cancer 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Bony Metastases From Castrate Refractory Prostate Cancer 1Bone Neoplasms 1Bone Metastases 1Bone Diseases 1

Interventions

enzalutamide 6radium Ra 223 dichloride 5Docetaxel 2Abiraterone Acetate 2zimberelimab 1xentuzumab 1sacituzumab govitecan 1quemliclustat 1pembrolizumab 1atezolizumab 1apalutamide 1Standard of Care 1Radium-223 1Prednisone 1Nivolumab 1Ipilimumab 1Drug Therapy 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Prostatic Neoplasms, Castration-Resistant × radium Ra 223 dichloride × Clear all
NCT02803437 2025-07-10

Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases

Bayer

Completed
334 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT02398526 2021-11-02

PARABO

Bayer

Completed
363 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT02450812 2021-11-02

URANIS

Bayer

Completed
86 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT03563014 2020-05-20

BELFIGO

Bayer

Completed
164 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT02899104 2020-03-31

Navigant

Bayer

Completed
200 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡